Chemical Component Summary

Name3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
Identifiers3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodo-phenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione
FormulaC17 H15 F2 I N4 O4
Molecular Weight504.23
TypeNON-POLYMER
Isomeric SMILESCN1C2=C(C(=C(C1=O)F)Nc3ccc(cc3F)I)C(=O)N(C=N2)C[C@H](CO)O
InChIInChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1
InChIKeyRCLQNICOARASSR-SECBINFHSA-N

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count1
Bond Count45
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB12241 
NameTAK-733
Groupsinvestigational
DescriptionTAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.
SynonymsTAK-733
Categories
  • Pyridines
  • Pyrimidines
CAS number1035555-63-5

Related Resource References

Resource NameReference
PubChem24963252
ChEMBLCHEMBL1615025
PharosCHEMBL1615025